Breast Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People diagnosed with a specific subtype of breast cancer called "Luminal B-like," with a tumour classified as a certain early stage (known as cT1 or cT2, meaning the tumour is relatively small)
- People for whom doctors have recommended chemotherapy given before surgery (called neoadjuvant chemotherapy)
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are currently pregnant
- People who are currently breastfeeding
- People who would not be able to attend follow-up appointments after joining the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alessio G Morganti, MD, PhD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phone: +39 0512143564
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
pCR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.